CCIA
Campbell & Co Investment Adviser Portfolio holdings
AUM
$1.59B
1-Year Return
6.26%
This Quarter Return
+1.48%
1 Year Return
+6.26%
3 Year Return
+31.56%
5 Year Return
+71.41%
10 Year Return
+132.34%
AUM
$371M
AUM Growth
+$79M
(+27%)
Cap. Flow
+$83.8M
Cap. Flow
% of AUM
22.59%
Top 10 Holdings %
Top 10 Hldgs %
6.32%
Holding
972
New
379
Increased
184
Reduced
115
Closed
294
Top Buys
| 1 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
$2.83M |
| 2 |
Reliance Steel & Aluminium
RS
|
$2.6M |
| 3 |
Costco
COST
|
$2.59M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$2.32M |
| 5 |
Eli Lilly
LLY
|
$2.23M |
Top Sells
| 1 |
Medtronic
MDT
|
$2.87M |
| 2 |
Lennar Class A
LEN
|
$2.79M |
| 3 |
Conagra Brands
CAG
|
$2.49M |
| 4 |
WEX
WEX
|
$2.24M |
| 5 |
Stifel
SF
|
$2.15M |
Sector Composition
| 1 | Technology | 15.96% |
| 2 | Healthcare | 14.27% |
| 3 | Industrials | 12.95% |
| 4 | Energy | 10.34% |
| 5 | Materials | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEX
601
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $214K | 0.06% |
+23,212
| New | +$214K |
|
602
Axos Financial
AX
$5.13B
| $213K | 0.06% |
+4,600
| New | +$213K |
|
|
DRD
603
DRDGold
DRD
$1.83B
| $213K | 0.06% |
+22,700
| New | +$213K |
|
|
FLIC
604
DELISTED
First of Long Island Corp
FLIC
| $212K | 0.06% |
+10,916
| New | +$212K |
|
605
MarineMax
HZO
$568M
| $212K | 0.06% |
5,277
+211
| +4% | +$8.48K |
|
606
Idexx Laboratories
IDXX
$51.4B
| $212K | 0.06% |
387
-521
| -57% | -$285K |
|
607
McGrath RentCorp
MGRC
$3.09B
| $212K | 0.06% |
+2,500
| New | +$212K |
|
608
Gorman-Rupp
GRC
$1.14B
| $211K | 0.06% |
+5,884
| New | +$211K |
|
609
STAG Industrial
STAG
$6.9B
| $211K | 0.06% |
5,100
-1,900
| -27% | -$78.6K |
|
610
Village Super Market
VLGEA
$549M
| $211K | 0.06% |
+8,600
| New | +$211K |
|
611
Community Trust Bancorp
CTBI
$1.06B
| $210K | 0.06% |
+5,109
| New | +$210K |
|
612
Hawaiian Electric Industries
HE
$2.12B
| $210K | 0.06% |
+4,972
| New | +$210K |
|
613
RE/MAX Holdings
RMAX
$194M
| $210K | 0.06% |
+7,573
| New | +$210K |
|
614
Dorman Products
DORM
$5B
| $209K | 0.06% |
2,200
-9,000
| -80% | -$855K |
|
615
Prestige Consumer Healthcare
PBH
$3.2B
| $209K | 0.06% |
+3,939
| New | +$209K |
|
616
Douglas Emmett
DEI
$2.83B
| $208K | 0.06% |
+6,230
| New | +$208K |
|
617
United Natural Foods
UNFI
$1.75B
| $208K | 0.06% |
+5,022
| New | +$208K |
|
618
Penumbra
PEN
$11B
| $207K | 0.06% |
+933
| New | +$207K |
|
619
Pool Corp
POOL
$12.4B
| $207K | 0.06% |
490
-60
| -11% | -$25.3K |
|
620
Dr. Reddy's Laboratories
RDY
$11.9B
| $207K | 0.06% |
+18,610
| New | +$207K |
|
621
Natera
NTRA
$23.1B
| $206K | 0.06% |
+5,055
| New | +$206K |
|
622
Bristol-Myers Squibb
BMY
$96B
| $205K | 0.06% |
2,801
-2,099
| -43% | -$154K |
|
623
Descartes Systems
DSGX
$9.26B
| $205K | 0.06% |
2,800
-500
| -15% | -$36.6K |
|
624
Herc Holdings
HRI
$4.6B
| $205K | 0.06% |
+1,229
| New | +$205K |
|
625
KLA
KLAC
$119B
| $205K | 0.06% |
+560
| New | +$205K |
|